1,241
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Cost effectiveness of direct acting antivirals in the treatment of hepatitis C in vulnerable populations

Pages 9-12 | Received 18 Sep 2020, Accepted 15 Oct 2020, Published online: 28 Oct 2020

Figures & data

Table 1. Summary of select cost-effective studies in vulnerable populations*

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.